Linked Data API

Show Search Form

Search Results

668995
unstar this property registered interest false more like this
star this property date less than 2017-01-06more like thismore than 2017-01-06
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
unstar this property hansard heading In Vitro Fertilisation remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what estimate he has made of the number of human eggs that would be required annually for (a) pro-nuclear transfer and (b) maternal spindle transfer should the NHS provide mitochondrial transfer. more like this
star this property tabling member constituency Congleton more like this
star this property tabling member printed
Fiona Bruce more like this
star this property uin 58665 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-01-16more like thismore than 2017-01-16
star this property answer text <p>The Human Fertilisation and Embryology Authority (HFEA) has advised that no estimate has been made of the number of human eggs that would be required annually for the maternal spindle transfer (MST) and pronuclear transfer (PNT) mitochondrial donation techniques. The number of eggs required will depend on the number of clinics who are licensed to perform the techniques, the number of patients they treat and the number of eggs required in the treatment of each patient.</p><p> </p><p>The independent expert panel convened by the HFEA published its fourth review into the safety and efficacy of mitochondrial donation on 30 November 2016. The expert panel made a number of recommendations on the potential avenues for laboratory research around mitochondrial donation techniques, which the HFEA supports.</p><p> </p><p>In terms of any subsequent treatments which may be offered, Regulations made under the Human Fertilisation and Embryology Act 1990, as amended, only permit the MST and PNT techniques to be used in treatment. Further research may lead to refinement of these techniques but the clinical use of any alternative mitochondrial donation techniques would require new legislation.</p>
star this property answering member constituency Oxford West and Abingdon more like this
star this property answering member printed Nicola Blackwood more like this
star this property grouped question UIN 58666 more like this
star this property question first answered
less than 2017-01-16T17:18:07.01Zmore like thismore than 2017-01-16T17:18:07.01Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
3958
unstar this property label Biography information for Fiona Bruce more like this
668996
unstar this property registered interest false more like this
star this property date less than 2017-01-06more like thismore than 2017-01-06
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
unstar this property hansard heading In Vitro Fertilisation remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what estimate he has made of the potential of (a) research into the use of mitochondrial transfer techniques and (b) subsequent treatments which may be offered on the NHS. more like this
star this property tabling member constituency Congleton more like this
star this property tabling member printed
Fiona Bruce more like this
star this property uin 58666 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-01-16more like thismore than 2017-01-16
star this property answer text <p>The Human Fertilisation and Embryology Authority (HFEA) has advised that no estimate has been made of the number of human eggs that would be required annually for the maternal spindle transfer (MST) and pronuclear transfer (PNT) mitochondrial donation techniques. The number of eggs required will depend on the number of clinics who are licensed to perform the techniques, the number of patients they treat and the number of eggs required in the treatment of each patient.</p><p> </p><p>The independent expert panel convened by the HFEA published its fourth review into the safety and efficacy of mitochondrial donation on 30 November 2016. The expert panel made a number of recommendations on the potential avenues for laboratory research around mitochondrial donation techniques, which the HFEA supports.</p><p> </p><p>In terms of any subsequent treatments which may be offered, Regulations made under the Human Fertilisation and Embryology Act 1990, as amended, only permit the MST and PNT techniques to be used in treatment. Further research may lead to refinement of these techniques but the clinical use of any alternative mitochondrial donation techniques would require new legislation.</p>
star this property answering member constituency Oxford West and Abingdon more like this
star this property answering member printed Nicola Blackwood more like this
star this property grouped question UIN 58665 more like this
star this property question first answered
less than 2017-01-16T17:18:07.213Zmore like thismore than 2017-01-16T17:18:07.213Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
3958
unstar this property label Biography information for Fiona Bruce more like this
668999
unstar this property registered interest false more like this
star this property date less than 2017-01-06more like thismore than 2017-01-06
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
unstar this property hansard heading In Vitro Fertilisation remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, in how many licensable IVF treatment cycles at least 20 eggs were collected in the last five years for which figures are available. more like this
star this property tabling member constituency Congleton more like this
star this property tabling member printed
Fiona Bruce more like this
star this property uin 58675 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-01-16more like thismore than 2017-01-16
star this property answer text <p>The Human Fertilisation and Embryology Authority has advised that in the last five years where a full year’s figures are available (2010-2014), there were 17,194 cycles of treatment where at least 20 eggs were collected. This is out of a total number of 304,183 treatment cycles that took place within the same period.</p> more like this
star this property answering member constituency Oxford West and Abingdon more like this
star this property answering member printed Nicola Blackwood more like this
star this property question first answered
less than 2017-01-16T17:03:10.107Zmore like thismore than 2017-01-16T17:03:10.107Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
3958
unstar this property label Biography information for Fiona Bruce more like this
678665
unstar this property registered interest false more like this
star this property date less than 2017-01-25more like thismore than 2017-01-25
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
unstar this property hansard heading In Vitro Fertilisation remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what proportion of clinical commissioning groups offer three full cycles of IVF treatment paid for by the NHS. more like this
star this property tabling member constituency Great Grimsby more like this
star this property tabling member printed
Melanie Onn more like this
star this property uin 61799 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-01-30more like thismore than 2017-01-30
star this property answer text <p>In England and Wales, guidance on the provision of National Health Service funded in vitro fertilisation (IVF) treatment services is provided by the National Institute for Health and Care Excellence in its guideline ‘Fertility: Assessment and treatment for people with fertility problems’. To assist clinical commissioning groups (CCGs) to effectively commission IVF services for their local population, the Department, NHS England, professional and stakeholder groups are working together to develop a benchmark price for IVF to ensure that CCGs can get best value for their money. Additionally, the Human Fertilisation and Embryology Authority, has developed commissioning guidance to improve the quality of commissioning. NHS England has agreed to disseminate and promote the guidance to all CCGs in England.</p><p> </p><p>The provision of funded treatment services in other parts of the United Kingdom is a matter for the devolved administrations.</p><p> </p><p>Information on local provision of NHS funded IVF treatment is not collected centrally. A survey carried out by Fertility Fairness in 2016 indicated that 16% of CCGs in England offered three cycles of IVF to qualifying couples.</p>
star this property answering member constituency Oxford West and Abingdon more like this
star this property answering member printed Nicola Blackwood more like this
star this property grouped question UIN 61798 more like this
star this property question first answered
less than 2017-01-30T15:35:30.447Zmore like thismore than 2017-01-30T15:35:30.447Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4464
unstar this property label Biography information for Melanie Onn more like this
678666
unstar this property registered interest false more like this
star this property date less than 2017-01-25more like thismore than 2017-01-25
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
unstar this property hansard heading In Vitro Fertilisation remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps he is taking to ensure equal access to IVF treatment across the UK. more like this
star this property tabling member constituency Great Grimsby more like this
star this property tabling member printed
Melanie Onn more like this
star this property uin 61798 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-01-30more like thismore than 2017-01-30
star this property answer text <p>In England and Wales, guidance on the provision of National Health Service funded in vitro fertilisation (IVF) treatment services is provided by the National Institute for Health and Care Excellence in its guideline ‘Fertility: Assessment and treatment for people with fertility problems’. To assist clinical commissioning groups (CCGs) to effectively commission IVF services for their local population, the Department, NHS England, professional and stakeholder groups are working together to develop a benchmark price for IVF to ensure that CCGs can get best value for their money. Additionally, the Human Fertilisation and Embryology Authority, has developed commissioning guidance to improve the quality of commissioning. NHS England has agreed to disseminate and promote the guidance to all CCGs in England.</p><p> </p><p>The provision of funded treatment services in other parts of the United Kingdom is a matter for the devolved administrations.</p><p> </p><p>Information on local provision of NHS funded IVF treatment is not collected centrally. A survey carried out by Fertility Fairness in 2016 indicated that 16% of CCGs in England offered three cycles of IVF to qualifying couples.</p>
star this property answering member constituency Oxford West and Abingdon more like this
star this property answering member printed Nicola Blackwood more like this
star this property grouped question UIN 61799 more like this
star this property question first answered
less than 2017-01-30T15:35:30.387Zmore like thismore than 2017-01-30T15:35:30.387Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4464
unstar this property label Biography information for Melanie Onn more like this
679038
unstar this property registered interest false more like this
star this property date less than 2017-01-26more like thismore than 2017-01-26
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
unstar this property hansard heading In Vitro Fertilisation remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what steps the Government is taking to ensure that NICE guidance on the commissioning of IVF treatment is implemented in each clinical commissioning group. more like this
star this property tabling member constituency Chesterfield more like this
star this property tabling member printed
Toby Perkins more like this
star this property uin 61872 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-02-03more like thismore than 2017-02-03
star this property answer text <p>The availability of National Health Service funded in-vitro fertilisation (IVF) fertility treatment is a matter for local determination. In making decisions on the level of service provision, clinical commissioning groups (CCGs) take account of the health care needs and priorities of their local population. They are also expected to take account of the National Institute for Health and Care Excellence’s guideline ‘Fertility: Assessment and treatment for people with fertility problems’.</p><p> </p><p>To support CCGs to effectively commission IVF services, the Department, NHS England, professional and stakeholder groups are working together to develop a benchmark price for IVF to ensure that CCGs get the best value for their money. Additionally, the Human Fertilisation and Embryology Authority has developed commissioning guidance to improve the quality of commissioning. NHS England has agreed to disseminate and promote the guidance to all CCGs in England.</p> more like this
star this property answering member constituency Oxford West and Abingdon more like this
star this property answering member printed Nicola Blackwood more like this
star this property question first answered
less than 2017-02-03T14:48:07.587Zmore like thismore than 2017-02-03T14:48:07.587Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
3952
unstar this property label Biography information for Toby Perkins more like this
682337
unstar this property registered interest false more like this
star this property date less than 2017-01-31more like thismore than 2017-01-31
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
unstar this property hansard heading In Vitro Fertilisation remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, if he will make it his policy to ensure that there will be no restriction on IVF availability. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property uin 62548 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-02-08more like thismore than 2017-02-08
star this property answer text <p>It is the Government’s long-standing policy that National Health Service commissioners should have regard to the National Institute for Health and Care Excellence fertility guidelines in deciding local provision of in-vitro fertilization. It is clinical commissioning groups, which are led by general practitioners, that have the statutory responsibility to commission healthcare services that meet the needs of their whole population, reducing inequalities and improving care quality.</p> more like this
star this property answering member constituency Oxford West and Abingdon more like this
star this property answering member printed Nicola Blackwood more like this
star this property question first answered
less than 2017-02-08T16:22:45.23Zmore like thismore than 2017-02-08T16:22:45.23Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
4131
unstar this property label Biography information for Jim Shannon more like this
683037
unstar this property registered interest false more like this
star this property date less than 2017-02-01more like thismore than 2017-02-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
unstar this property hansard heading In Vitro Fertilisation remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, how many meetings his Department has had with (a) NHS England, (b) professional bodies and (c) stakeholder bodies to discuss the creation of a benchmark price for IVF. more like this
star this property tabling member constituency Washington and Sunderland West more like this
star this property tabling member printed
Mrs Sharon Hodgson more like this
star this property uin 62750 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-02-08more like thismore than 2017-02-08
star this property answer text <p>NHS England has advised that the in vitro fertilisation (IVF) benchmark price will be developed during 2017/18 with support from the IVF Expert Advisory Group and all key stakeholders, working towards publishing the IVF benchmark price ready for the financial year 2018/19. It is also planning to develop and test an IVF outcome based payment approach with a number of clinical commissioning groups and service providers in 2018/19.</p><p> </p><p>The issue of an IVF benchmark price was first raised at a meeting with my hon. Friend the former Parliamentary Under Secretary of State for Public Health (Jane Ellison) on 14 December 2015, attended by NHS England officials and stakeholders. There was a subsequent follow up meeting between the Department and NHS England on 10 May 2016. NHS England met with professionals groups and stakeholders on 24 June 2016 and established the IVF Expert Advisory Group, whose membership includes NHS England, the Department, National Health Service commissioners, the Human Fertilisation and Embryology Authority, professional groups and patient stakeholders. The Expert Advisory Group met for the first time on 11 November 2016 and is scheduled to meet again on 3 March 2017. A wider stakeholder workshop also took place on 9 December 2016.</p>
star this property answering member constituency Oxford West and Abingdon more like this
star this property answering member printed Nicola Blackwood more like this
star this property grouped question UIN 62749 more like this
star this property question first answered
less than 2017-02-08T16:24:52.5Zmore like thismore than 2017-02-08T16:24:52.5Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
1521
unstar this property label Biography information for Mrs Sharon Hodgson more like this
683041
unstar this property registered interest false more like this
star this property date less than 2017-02-01more like thismore than 2017-02-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
unstar this property hansard heading In Vitro Fertilisation remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what the timescale is for deciding and publishing the benchmark price for IVF. more like this
star this property tabling member constituency Washington and Sunderland West more like this
star this property tabling member printed
Mrs Sharon Hodgson more like this
star this property uin 62749 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-02-08more like thismore than 2017-02-08
star this property answer text <p>NHS England has advised that the in vitro fertilisation (IVF) benchmark price will be developed during 2017/18 with support from the IVF Expert Advisory Group and all key stakeholders, working towards publishing the IVF benchmark price ready for the financial year 2018/19. It is also planning to develop and test an IVF outcome based payment approach with a number of clinical commissioning groups and service providers in 2018/19.</p><p> </p><p>The issue of an IVF benchmark price was first raised at a meeting with my hon. Friend the former Parliamentary Under Secretary of State for Public Health (Jane Ellison) on 14 December 2015, attended by NHS England officials and stakeholders. There was a subsequent follow up meeting between the Department and NHS England on 10 May 2016. NHS England met with professionals groups and stakeholders on 24 June 2016 and established the IVF Expert Advisory Group, whose membership includes NHS England, the Department, National Health Service commissioners, the Human Fertilisation and Embryology Authority, professional groups and patient stakeholders. The Expert Advisory Group met for the first time on 11 November 2016 and is scheduled to meet again on 3 March 2017. A wider stakeholder workshop also took place on 9 December 2016.</p>
star this property answering member constituency Oxford West and Abingdon more like this
star this property answering member printed Nicola Blackwood more like this
star this property grouped question UIN 62750 more like this
star this property question first answered
less than 2017-02-08T16:24:52.453Zmore like thismore than 2017-02-08T16:24:52.453Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
1521
unstar this property label Biography information for Mrs Sharon Hodgson more like this
686166
unstar this property registered interest false more like this
star this property date less than 2017-02-07more like thismore than 2017-02-07
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
unstar this property hansard heading In Vitro Fertilisation remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what his policy is on clinical trials to genetically modify human embryos by means of mitochondrial transfer techniques with the intention of bringing those human embryos to full term and giving birth to them; and what assessment he has made of the risks to the health of trial subjects. more like this
star this property tabling member constituency Congleton more like this
star this property tabling member printed
Fiona Bruce more like this
star this property uin 63363 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-02-10more like thismore than 2017-02-10
star this property answer text <p>The Human Fertilisation and Embryology Authority decided on 15 December 2016 to allow the use mitochondrial donation for risk reduction treatments in certain cases where alternative treatments would be of little or no benefit to mothers at risk of passing mitochondrial disease onto their children. This decision was taken after considering the independent Expert Panel’s fourth report on the latest evidence of safety and efficacy and following a comprehensive and rigorous process of assessment and review of the scientific evidence over the last six years. Before any treatment is offered to affected families, there are still two more licencing processes to be completed. The first to ensure that the clinic meets the required suitability standards and the second a case by case assessment of each individual as required by the Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015.</p><p> </p><p>NHS England is the designated commissioner of the National Health Service service for mitochondrial donation and will fund the treatment costs of the service, alongside an evaluative research project funded by the Wellcome Trust, which will assess and monitor follow-up and outcomes.</p><p> </p><p>Mitochondrial donation does not fit within the definition in law of a clinical trial for the purpose of compliance with the EU Clinical Trial Directive 2001/20/EC. The Directive relates to clinical trials of medicinal products governed by the medicines licensing regime set out in the Medicinal Products Directive and is part of a suite of European measures which set out common rules across the European Union to ensure the free movement of safe medicines.</p><p> </p><p>The Government does not agree with the characterisation of mitochondrial donation as a form of genetic modification. The mitochondrial donation techniques do not involve the germ-line modification of nuclear DNA in the chromosomes that can be passed on to future generations, which is the Chief Medical Officer’s working definition of genetic modification in humans.</p><p> </p><p>NHS England nationally commissions the rare mitochondrial disease service for adults and children, which provides a comprehensive diagnostic service for patients suffering from mitochondrial disease.</p>
star this property answering member constituency Oxford West and Abingdon more like this
star this property answering member printed Nicola Blackwood more like this
star this property grouped question UIN 63365 more like this
star this property question first answered
less than 2017-02-10T09:50:02.067Zmore like thismore than 2017-02-10T09:50:02.067Z
star this property answering member
4019
star this property label Biography information for Baroness Blackwood of North Oxford more like this
star this property tabling member
3958
unstar this property label Biography information for Fiona Bruce more like this